Personalized medicine is paving the way for a superior health care system by custom-fitting treatment to a patient's unique genetic blueprint. PMWC 2010 (Personalized Medicine World Conference) will examine this emerging field that is already providing benefits for the health care industry, while simultaneously creating business opportunities within the Lifesciences
PMWC 2010 is a 2-day educational and business conference on Personalized Medicine - the first large conference of its kind in the Silicon Valley.
Topics that will be covered:
Personalized medicine diagnostics and therapeutics that are already helping to revolutionize treatment for major indications like cancer and heart disease
How companies and government are working together to create solid policy to overcome the regulatory and safety challenges of pioneering the new frontiers of Personalized Medicine
Presentations by up-and-coming companies that are creating technologies that will save costs by eliminating unnecessary treatments and improving patient outcomes
A technology showcase will feature select companies recognized for their breakthrough products and services. In addition we will hold a company competition that will showcase selected companies and top 5 finalist companies.
El Camino Hospital Palo Alto Medical Foundation Genomic Health Synergenics Bio Center Stanford Hospital and Clinics Stanford University Complete Genomics CMEA FDA PMC DNA-Direct UCSF Pfizer Takeda Pharmaceuticals San Francisco Sanofi-aventis D2S NBC Bay Area AstraZeneca Merck KPCB Claremont Creek Ventures Elixior Kaiser Navigenics IBM Technion-Israel Channel 7 News NBC Bay Area News BayBio Dell NIST, US Government Mohr Davidow Ventures New Leaf Venture Partners New York Times Morrison Foerster Foley Hoag Draper Fisher Jurvetson PHYSIC Ventures DNA Nexus MKS Instruments DNA guide Bloomberg News Tethys Bioscience Genentech Reproductive Science Center SF Bay IBM Research Lab Silicom Ventures InstantCal USVP Life Science Angels Bioequities Quantalife Institute for the Future (IFTF) Muir Partners Pitango Venture Capital DNAGenotek Crescendo Biosciences Intel Quantalife Bosch HolGenTech Complete Genomics Theranos Nixon Peabody Stem Cells Inc. TheraOne Canary Foundation KPMG EDventure Holdings HydraDx Citala Agility Bio MedStars Charter Life Sciences Frost & Sullivan Magnolia Capital ReadiSorb LifeWave Inc. InterWest Partners Quantalife DCG Systems Charter Life Sciences Chronix BiomedicalDraper Fisher Jurvetson Compendia Bioscience Skyline Ventures Roche Singularity Hub Kedge Ventures Progen Pharmaceuticals Biologics Consulting Group MEDgle XDx NOST- The Netherlands Government Mountain View Pharmaceuticals incellDx CardioDx Pathway Genomics DNA Genotek San Francisco State University Aposese Itd. CollaBrx BIRD Foundation (Israel - US) Pacific Biosciences, Inc. Palo Alto Research Center Affymetrix Hometown Healthcare Uniconnect Yodan Ventures Weizmann Institute of Science Uzia Center for Medical Informatics, Telemedicine and Personalized Medicine Israeli Counsulate Soar BioDynamics Mohr Davidow Ventures Inforel Technologies IBM Venture Capital Group Tech News World Medical Tactile Institute for Systems Biology Edgewood Venture Partners MIT Technology Review Deutschland Advanced Technology Ventures Market Ready Rx , Inc Systemics Novartis Ubuntu LLC VentureDeal University of São Paulo Cancer Institute Life Technologies NVIDIA Foundation National Institute of Standards and Technology Band of Angels The Addario Lung Cancer Medical Institute (ALCMI) Open Medicine Institute Corbett Accel Healthcare Group Select Biosciences UK Applied BiosystemsBoston Heart Labs Fujifilm Medical Systems USA, Inc. Healthcare Journal of North California California Medical Association New Centure Healthcare Institution 2020 GeneSystems, Inc. Executive Talks Telegraph Hill Partners Rainbow Bioscience Rappaport Faculty of Medicine & Research Institute IO Informatics Instituto Avanços em Medicina Longitude Capital Juvenile Diabetes Research Foundation Evolvence India Life Science Fund Intel AFFYMETRIX, INC.